Latest Competition News

COG Financial Services lifted revenue 10% to $403.4 million and net profit after tax attributable to members by 29% to $24.24 million for FY26, driven by a 51% jump in its Salary Packaging segment including the Easifleet acquisition. The company declared a fully franked 7.0 cents per share dividend, suspending its dividend reinvestment plan.

Prescient Therapeutics (ASX:PTX) has opened a $7 million Share Purchase Plan at a significant discount to advance its lead cancer therapy PTX-100 beyond a pivotal Dose Optimisation Committee review in late 2026.

Hiremii Limited posted an 8.6% revenue increase to $32.4 million and halved its net loss in FY26, reaching adjusted EBITDA breakeven as it prepares to rebrand as AQYR Limited.

Lovisa Holdings reported a robust FY26 with revenue up 17.6% to A$938.8 million, expanded its global store network to 1,136 locations, and declared a 33 cent final dividend, reflecting strong momentum in key markets.

FleetPartners has received a fresh non-binding offer from a Sumitomo-led consortium valuing the company at $3.85 per share, joining a competitive field of bidders vying for control.

FOS Capital reported a 12% revenue decline and an EBITDA loss of $0.5 million in FY26, impacted by softer market conditions and project delays. However, a $10 million order book and record $130 million pipeline set the stage for a potential turnaround in FY27.

Golden Deeps has kicked off a deeper diamond drilling program at its Graceland discovery in Namibia, aiming to test high-grade copper-silver-zinc-lead-germanium sulphide zones analogous to the world-class Tsumeb deposit. Recent shallow drilling confirmed continuity of exceptional grades, underpinning the exploration push.

HiTech Group has secured unconditional ACCC clearance for its acquisition of Hudson Global Resources’ Australian assets, removing a major regulatory obstacle ahead of completion.

Atturra Limited’s FY26 results reveal a sharp net loss driven by a $22.8 million goodwill impairment, overshadowing a 17% revenue increase to $351.8 million. The company is banking on AI and strategic acquisitions to fuel a turnaround in FY27.

Monvia Limited reported a $28.7 million revenue year with a $6.9 million adjusted EBITDA, exceeding IPO forecasts, while renewing a $60 million contract with MetLife and completing its ASX listing.

Steel & Tube Holdings reported a 13.9% revenue rise and a 376% jump in normalised EBITDA for FY26, despite a statutory net loss of NZD 61.2 million driven by significant asset impairments and ongoing market challenges.

Racura Oncology's FY2026 results reveal a widening loss despite a 22% revenue dip, underpinned by significant scientific progress on its lead drug targeting the elusive MYC gene and a robust $34.3 million cash position.